Editorial: The Treatment of RAS or BRAF Mutated Metastatic Colorectal Cancer: Challenges and Perspectives

被引：1
|
作者：
Ottaiano, Alessandro [1 ]
Berretta, Massimiliano [2 ]
Von Arx, Claudia [1 ]
Capozzi, Monica [1 ]
Caraglia, Michele [3 ]
机构：
[1] Ist Ric & Cura Carattere Sci IRCCS G Pascale, Ist Nazl Tumori Napoli, Naples, Italy
[2] Univ Messina, Dept Clin & Expt Med, Messina, Italy
[3] Univ Campania L Vanvitelli, Dept Precis Med, Naples, Italy
来源：
FRONTIERS IN ONCOLOGY | 2022年 / 12卷
关键词：
colorectal cancer; KRAS; BRAF; prognosis; therapy;
D O I：
10.3389/fonc.2022.852445
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页数：2
相关论文
共 50 条
  • [21] The heterogeneous clinical and pathological landscapes of metastatic Braf-mutated colorectal cancer
    Fanelli, Giuseppe Nicolo
    Dal Pozzo, Carlo Alberto
    Depetris, Ilaria
    Schirripa, Marta
    Brignola, Stefano
    Biason, Paola
    Balistreri, Mariangela
    Dal Santo, Luca
    Lonardi, Sara
    Munari, Giada
    Loupakis, Fotios
    Fassan, Matteo
    CANCER CELL INTERNATIONAL, 2020, 20 (01)
  • [22] An Unusual Combination: KRAS and BRAF Co-mutated Metastatic Colorectal Cancer
    Epperla N.
    George B.
    Journal of Gastrointestinal Cancer, 2016, 47 (2) : 206 - 209
  • [23] Progression-free survival in metastatic, BRAF-mutated colorectal cancer
    Morris, Van Karlyle
    Overman, Michael J.
    Maru, Dipen M.
    Kopetz, Scott
    JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (04)
  • [24] BRAF V600E-mutated Colorectal Neuroendocrine Carcinoma Effectively Treated with a Chemotherapy Protocol for BRAF-mutated Metastatic Colorectal Cancer
    Owaki, Seira
    Mori, Yoshinori
    Nakai, Shunsuke
    Maeda, Hideki
    Imazu, Mitsuki
    Tomita, Yusaku
    Kanaiwa, Hiroki
    Yamaguchi, Ayana
    Kitagawa, Mika
    Hirano, Atsuyuki
    Kimura, Yoshihide
    Tsuchida, Kenji
    Kataoka, Hiromi
    INTERNAL MEDICINE, 2024, 63 (14) : 1995 - 1999
  • [25] The role of concomitant RAS and BRAF mutations in influencing clinical outcome during BRAF-targeted treatment for metastatic colorectal cancer
    Pretta, A.
    Ziranu, P.
    Spanu, D.
    Lai, E.
    Dettori, M.
    Manai, C.
    Balconi, F.
    Intini, R.
    Murgia, S.
    Leone, A. G.
    Pozzari, M.
    Rasola, C.
    Bardanzellu, F.
    Maddalena, G.
    Pusceddu, V.
    Puzzoni, M.
    Pietrantonio, F.
    Bergamo, F.
    Lonardi, S.
    Scartozzi, M.
    ANNALS OF ONCOLOGY, 2022, 33 (07) : S707 - S707
  • [26] Targeting BRAF and RAS in Colorectal Cancer
    Bellio, Helene
    Fumet, Jean David
    Ghiringhelli, Francois
    CANCERS, 2021, 13 (09)
  • [27] Pre-clinical modelling and treatment of BRAF mutated colorectal cancer
    White, M.
    Lannagan, T.
    McGarry, L.
    Carlin, L.
    Mills, M.
    Yazgili, A. S.
    Ridgway, R.
    Jackstadt, R.
    Campbell, A. D.
    Wilson, R. H.
    Sansom, O. J.
    ANNALS OF ONCOLOGY, 2023, 34 : S195 - S195
  • [28] BRAF-Mutated Colorectal Cancer: What Is the Optimal Strategy for Treatment?
    Romain Cohen
    Pascale Cervera
    Magali Svrcek
    Anna Pellat
    Chantal Dreyer
    Aimery de Gramont
    Thierry André
    Current Treatment Options in Oncology, 2017, 18
  • [29] BRAF-Mutated Colorectal Cancer: What Is the Optimal Strategy for Treatment?
    Cohen, Romain
    Cervera, Pascale
    Svrcek, Magali
    Pellat, Anna
    Dreyer, Chantal
    de Gramont, Aimery
    Andre, Thierry
    CURRENT TREATMENT OPTIONS IN ONCOLOGY, 2017, 18 (02)
  • [30] Role of blood metabolites in mediating the effect of gut microbiome on the mutated-RAS/BRAF metastatic colorectal cancer-specific survival
    Xiang, Yaoxian
    Zhang, Chan
    Wang, Jing
    Cheng, Yurong
    Wang, Kangjie
    Wang, Li
    Tong, Yingying
    Yan, Dong
    INTERNATIONAL JOURNAL OF COLORECTAL DISEASE, 2024, 39 (01)
12345